Business News • MarketWire • Abeona Therapeutics, Inc. to Present on CRISPR/CAS9 Technology Platform Progress at CRISPR Precision Gene Editing Congress

Abeona Therapeutics, Inc. to Present on CRISPR/CAS9 Technology Platform Progress at CRISPR Precision Gene Editing Congress

Abeona Therapeutics, Inc. to Present on CRISPR/CAS9 Technology Platform Progress at CRISPR Precision Gene Editing Congress

NEW YORK, NY and CLEVELAND, OH--(Marketwired - February 24, 2016) - Abeona Therapeutics, Inc. (NASDAQ: ABEO), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, today announced being featured in both a Poster and Abstract Presentation at the 2nd Annual CRISPR Precision Gene Editing Congress in Boston, MA. The Poster and Abstract session will focus on CRISPR/Cas9 as a Promising Gene Editing Tool for Fanconi anemia and other rare blood disorders.

View More : http://www.marketwired.com/mw/release.do?id=2099854&sourceType=3

Releted News by marketwire

U.S. Housing Market Continues Its Steady Comeback

Logix Federal Credit Union Announces $5 Million Member Loyalty Dividend